Unusual hypertrophic cardiomyopathy with severe right ventricular outflow tract obstruction and two septal aneurysms:

Yangyang Sun1, Shengcong Liu1, Jianping Li2,3

  • 1Department of Cardiology, Peking University First Hospital, Xishiku 8, Xicheng District, Beijing, 100034, China.

Insights

Severe right ventricular outflow tract (RVOT) obstruction caused by hypertrophic cardiomyopathy (HCM) is rare. This case highlights unique cardiac features and novel genetic mutations in HCM, emphasizing individualized management and genotype-phenotype correlation.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Case Studies

Background:

  • Hypertrophic cardiomyopathy (HCM) typically involves left ventricular thickening, but right ventricular (RV) involvement is common and linked to poorer prognosis.
  • Right ventricular outflow tract (RVOT) obstruction is rare, with HCM being a prevalent cause.
  • Severe RVOT obstruction due to HCM is seldom reported, necessitating further investigation into its characteristics.

Purpose of the Study:

  • To describe a rare case of severe RVOT obstruction caused by HCM.
  • To characterize the unique phenotypic and genetic features of this HCM presentation.
  • To discuss the clinical implications and management of such rare cases.

Main Methods:

  • A case report of a 33-year-old woman with severe RVOT obstruction due to HCM.
  • Diagnostic methods included imaging, genetic testing, and histological findings.
  • The patient underwent RVOT myectomy, with follow-up echocardiography.

Main Results:

  • The patient presented with severe RVOT obstruction, apical hypertrophy, and septal/atrial aneurysms.
  • Genetic testing identified three novel mutation sites associated with cardiomyopathy.
  • Post-myectomy, echocardiography showed improved RV function and reduced RVOT pressure gradient.

Conclusions:

  • Isolated severe RVOT obstruction from HCM is rare and requires differentiation from congenital heart diseases.
  • Management should be individualized, guided by HCM principles.
  • This case demonstrates phenotypic and genetic heterogeneity in HCM, contributing to understanding genotype-phenotype correlations.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460